Market Overview

Benzinga's Top #PreMarket Gainers

Related PATH
Benzinga's M&A Chatter for Tuesday January 21, 2014
Teva Acquires NuPathe for $3.65/Share in Cash, Plus Up to $3.15/Share Based on Zecuity Sales
Related ENDP
Don't Worry Spec. Pharma Investors, Drug Pricing Legislation Probably Won't Affect You
Worst Performing Industries For October 5, 2015
AcelRx Updates on Zalviso for Pain Management Treatment (Zacks)

NuPathe (NASDAQ: PATH) surged 50.43% to $3.46 in the pre-market session after the company agreed to be acquired by Endo Health Solutions (NASDAQ: ENDP) for $2.85 per share in cash.

Solta Medical (NASDAQ: SLTM) soared 21.05% to $2.53 in the pre-market trading after Valeant Pharmaceuticals (NYSE: VRX) agreed to acquire Solta Medical for $2.92 per share in cash.

AcelRx Pharmaceuticals (NASDAQ: ACRX) shares jumped 9.15% to $8.95 in pre-market trading after the company announced the collaboration for EU commercialization of ZALVISO.

YRC Worldwide (NASDAQ: YRCW) shares gained 3.28% to $12.90 in the pre-market. YRC Worldwide shares have jumped 81.28% over the past 52 weeks, while the S&P 500 index has gained 24.12% in the same period.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers


Related Articles (ENDP + ACRX)

Get Benzinga's Newsletters